Trump Cuts a Deal With AstraZeneca to Lower Drug Prices

The Trump administration has reached an agreement with pharmaceutical company AstraZeneca to lower drug prices. The deal was facilitated by the threat of tariffs, as confirmed by the president and top health officials. This agreement is part of the administration's broader efforts to negotiate lower prices with various pharmaceutical companies. While details of the AstraZeneca deal have not been disclosed, it is seen as a significant step in the administration's ongoing push to address the issue of high drug costs in the United States. The article suggests that other pharmaceutical companies are still in negotiations with the White House, indicating that this may be the first of several such agreements to come. The deal with AstraZeneca highlights the administration's willingness to use its leverage, including the threat of tariffs, to achieve its goals in the healthcare sector.